Alyeska Investment Group L.P. bought a new position in Xylem Inc. (NYSE:XYL - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 73,332 shares of the industrial products company's stock, valued at approximately $8,760,000.
A number of other large investors have also bought and sold shares of XYL. Vanguard Group Inc. raised its position in Xylem by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company's stock valued at $3,465,122,000 after purchasing an additional 362,127 shares during the last quarter. Royal Bank of Canada grew its holdings in shares of Xylem by 7.9% during the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after purchasing an additional 320,500 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Xylem by 8.7% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock valued at $435,119,000 after buying an additional 301,070 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after buying an additional 3,239,203 shares during the last quarter. Finally, Northern Trust Corp lifted its position in Xylem by 2.9% during the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company's stock worth $401,743,000 after buying an additional 94,560 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
XYL has been the subject of several research reports. Citigroup restated a "buy" rating and issued a $152.00 price objective (up previously from $137.00) on shares of Xylem in a research report on Monday, July 14th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. UBS Group boosted their price objective on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research report on Tuesday, August 5th. JPMorgan Chase & Co. began coverage on Xylem in a research report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Finally, TD Cowen lifted their target price on Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research note on Tuesday, August 26th. Six analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $152.29.
Read Our Latest Stock Report on Xylem
Xylem Trading Up 2.9%
XYL traded up $4.02 during trading on Thursday, reaching $141.75. 1,705,284 shares of the company's stock were exchanged, compared to its average volume of 1,032,381. The company's fifty day moving average price is $138.01 and its 200-day moving average price is $127.52. The firm has a market capitalization of $34.50 billion, a PE ratio of 36.82, a P/E/G ratio of 2.38 and a beta of 1.09. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same period last year, the company earned $1.09 EPS. The firm's revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's payout ratio is presently 41.56%.
Insider Activity at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report